พบ "Public health policy"ทั้งหมด 1,216 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
ฮ - ก
E^2U ฝ่ายวิจัยภายใต้ HITAP สร้างทางเลือก ‘นโยบายสุขภาพ’ บนความสัมพันธ์ ‘สวล.-ศก.’
โลกใบเดิมเปลี่ยนแปลงไปอย่างรวดเร็ว เมื่อกลางปี 2566 องค์การบริหารการบินและอวกาศแห่งชาติ (NASA) สำรวจพบว่า อุณหภูมิเฉลี่ยซีกโลกเหนือร้อนที่สุดในรอบ 170 ปี และหากเทียบเคียงกับ 25 ปีก่อน ขณะนี้น้ำแข็งละลายไวขึ้นมากถึง 6-7 เท่าตัว
อันโตนิโอ กูเตร์เรส เลขาธิการสหประชาชาติ (UN) ประกาศ
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the
Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car
Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car
Evidence-informed policy formulation the case of the voucher scheme for maternal and child health in Myanmar (2014)
Yot Teerawattananon,1 Sripen Tantivess,1 Pitsaphun Werayingyong,1
Pritaporn Kingkaew,1 Nilar Tin,2 San San Aye,3 Phone Myint3
Abstract
Introduction: In 2010, with financial support from the Global Alliance for Vaccine and Immunization’s Health System Strengthening programme, the Government of
Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan. (2009)
Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan.
Thidaporn Jirawattanapisal1 Pritaporn Kingkaew2 Tae-Jin Lee3 Ming-Chin Yang4
1International Health Policy Program, Ministry of Public Health, Muang Nonthaburi,Thailand;
2
Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges
Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster
EU agency lifts lid on drug data secrets
(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E
10 / หน้า